A Practice Primer and Update on Anti-Bacterial Resistance.

Pak Ho Au, Mustafa Gandhi, Kathryn Deere, Jina Patel, Hariharan Regunath

Abstract readReview

In one paragraph

Review in Missouri medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pak Ho AuFellow, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Mustafa GandhiFellow, Department of Medicine-Division of Gastroenterology, University of Missouri-Columbia, Columbia, Missouri, USA.

Kathryn DeereClinical Pharmacist, Pulmonary and Critical Care Medicine, University of Maryland-Baltimore Washington Medical Center, Glen Burnie, Maryland, USA.

Jina PatelClinical Pharmacist, Pulmonary and Critical Care Medicine, University of Maryland-Baltimore Washington Medical Center, Glen Burnie, Maryland, USA.

Hariharan RegunathAttending Physician, Adult Critical Care Medicine and Infectious Diseases, University of Maryland-Baltimore Washington Medical Center, Glen Burnie, Maryland, USA; Adjunct Associate Professor, Department of Medicine-Division of Infectious Diseases, University of Missouri-Columbia, Columbia, Missouri, USA; and Consultant, Infectious Diseases, Lake Regional Health System, Osage Beach, Missouri, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is driven by inappropriate antibiotic use. Multi-drug resistance is a rising concern in Gram-negative bacteria. Prompt recognition and appropriate antibiotics are needed for improving outcomes. This is a practice primer for clinicians in the management of resistant infections that summarizes mechanisms, treatment, updates and the spectrum of activity for newer antibiotics, most relevant to current clinical practice.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialHumansAnti-Bacterial Agents

Identifiers

PMID40787034

PMCPMC12331293

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.